Defining the Communication Between Agonist and Coactivator Binding in the Retinoid X Receptor a Ligand Binding Domain

News   Nov 06, 2013

 
Defining the Communication Between Agonist and Coactivator Binding in the Retinoid X Receptor a Ligand Binding Domain
 
 
 

RELATED ARTICLES

New Opportunities for Type 2 Diabetes Drug Discovery: Researchers Determine Glucagon Receptor Structure

News

Complex structure of a class B GPCR bound to an analogue of its endogenous ligand ignites new excitement in GPCR research.

READ MORE

Innovative ALS Therapy Startup Wins Golden Ticket Funding From Amgen

News

Amgen and LabCentral have announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral.

READ MORE

MiNT Protein: A New Target to Treat Cancer, Diabetes and Other Diseases?

News

A two-faced protein in a chain that regulates iron and other elements in cells could provide a new target to treat cancer, diabetes and other diseases.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE